Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-09-15
2009-02-17
Graser, Jennifer E (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S234100, C424S236100, C424S235100, C424S193100, C424S197110, C424S200100, C530S350000, C435S242000, C435S252300, C435S252310
Reexamination Certificate
active
07491404
ABSTRACT:
The invention concerns an acellular immunogenic or vaccine composition for producing antibodies againstBacillus anthraciscomprising a protective antigen (PA) and killed and optionally purified spores, obtained from mutating strains ofBacillus anthracisand their uses.
REFERENCES:
patent: 0 739 981 (1996-10-01), None
XP-000922808, S. Welkos, et al., “Comparative safety and efficacy againstBacillus anthracisof protective antigen and live vaccines in mice”, Microbial Pathogenesis, 1988, vol. 5, No. 3, pp. 127-140.
XP-000215550, P. Turnbull, “Anthrax vaccines: past, present and future”, Guildford Surrey, GB, vol. 9, No. 8, Aug. 1991, pp. 533-539.
A. Stepanov, et al., “Development of novel vaccines against anthrax in man”, Journal of Biotechnology, vol. 44, No. 1, pp. 155-160, Jan. 26, 1996.
XP-000922839, V. Abalakin, et al., “Protective and other biological propeties ofBacillus anthracissoluble antigens”, vol. 35, No. 1, pp. 83-91, 1991.
XP-00214827, I. Kravets, et al., “Mixed anthrax vaccine having improved quality”, Res. Instit., Jul. 1998, Derwent abstract only.
XP-002141826, V. Abalakin, et al., Zhurnal Mikrobiologii, Epidemiologii, Immunologii, No. 5, 1990, pp. 72-75.
C. Pezard, et al., “Protective immunity induced byBacillus anthracistoxin-deficient strains”, Infection and Immunity, vol. 63, No. 4, Apr. 1995, pp. 1369-1372.
B. Ivins, et al., “Immunization studies with attenuated strains ofBacillus anthracis”, Infection and Immunity, vol. 52, No. 2, May 1986, pp. 454-458.
B. Ivins, et al., “Recent advances in the development of an improved human anthrax vaccine”, Eur. J. Epidemiol, vol. 4, No. 1, Mar. 1988, pp. 12-19.
Centre National de la Recherche Scientifique--CNRS
Graser Jennifer E
Institut Pasteur
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
LandOfFree
Acellular immunogenic compositions and acellular vaccine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acellular immunogenic compositions and acellular vaccine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acellular immunogenic compositions and acellular vaccine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112527